G
Graciela M. Nogueras-Gonzalez
Researcher at University of Texas MD Anderson Cancer Center
Publications - 95
Citations - 3123
Graciela M. Nogueras-Gonzalez is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 26, co-authored 79 publications receiving 2473 citations. Previous affiliations of Graciela M. Nogueras-Gonzalez include University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study
Jan A. Burger,Michael J. Keating,William G. Wierda,Elena Hartmann,Julia Hoellenriegel,Nathalie Y. Rosin,Iris de Weerdt,Ghayathri Jeyakumar,Alessandra Ferrajoli,Marylou Cardenas-Turanzas,Susan Lerner,Jeffrey L. Jorgensen,Graciela M. Nogueras-Gonzalez,Gracy Zacharian,Xuelin Huang,Hagop M. Kantarjian,Naveen Garg,Andreas Rosenwald,Susan O'Brien +18 more
TL;DR: The encouraging safety and activity of ibrutinib and rituximab in this population of patients with high-risk CLL merits further investigation of this combination.
Journal ArticleDOI
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.
Naval Daver,Guillermo Garcia-Manero,Sreyashi Basu,Prajwal Boddu,Mansour Alfayez,Jorge E. Cortes,Marina Konopleva,Farhad Ravandi-Kashani,Elias Jabbour,Tapan M. Kadia,Graciela M. Nogueras-Gonzalez,Jing Ning,Naveen Pemmaraju,Courtney D. DiNardo,Michael Andreeff,Sherry Pierce,Tauna Gordon,Steven M. Kornblau,Wilmer Flores,Zainab Al-Hamal,Carlos E. Bueso-Ramos,Jeffrey L. Jorgensen,Keyur P. Patel,Jorge Blando,James P. Allison,Padmanee Sharma,Hagop M. Kantarjian +26 more
TL;DR: Azacitidine in combination with nivolumab therapy produced an encouraging response rate and overall survival in patients with R/R AML, particularly in HMA-naïve and salvage 1 patients.
Journal ArticleDOI
The impact of age and gender on papillary thyroid cancer survival
Jacqueline Jonklaas,Graciela M. Nogueras-Gonzalez,Mark F. Munsell,Danielle R. Litofsky,Kenneth B. Ain,S T Bigos,Jim Brierley,David S. Cooper,Bryan R. Haugen,Paul W. Ladenson,James Magner,John A Robbins,Douglas S. Ross,Monica C. Skarulis,David L. Steward,Harry R. Maxon,Steven I. Sherman +16 more
TL;DR: Although the overall outcome of women with PTC is similar to men, subgroup analysis showed that this composite outcome is composed of two periods with different outcomes, raising the question of whether an older age cutoff would improve current staging systems.
Journal ArticleDOI
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia.
Jan A. Burger,Mariela Sivina,Nitin Jain,Ekaterina Kim,Tapan M. Kadia,Zeev Estrov,Graciela M. Nogueras-Gonzalez,Xuelin Huang,Jeffrey L. Jorgensen,Jianling Li,Mei Cheng,Fong Clow,Maro Ohanian,Michael Andreeff,Thomas Mathew,Philip A. Thompson,Hagop M. Kantarjian,Susan O'Brien,William G. Wierda,Alessandra Ferrajoli,Michael J. Keating +20 more
TL;DR: It is concluded that the addition of rituximab to ibrutinib in relapsed and treatment-naive high-risk patients with CLL failed to show improvement in PFS, and ibrUTinib as single-agent therapy remains current standard-of-care treatment in CLL.
Journal ArticleDOI
Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration under general anesthesia versus moderate sedation.
Roberto F. Casal,Donald R. Lazarus,Kristine Kuhl,Graciela M. Nogueras-Gonzalez,Sarah Perusich,Linda K. Green,Linda K. Green,David Ost,Mona Sarkiss,Carlos A. Jimenez,Georgie A. Eapen,Rodolfo C. Morice,Lorraine Cornwell,Lorraine Cornwell,Sheila Austria,Amir Sharafkanneh,Amir Sharafkanneh,Rolando E. Rumbaut,Rolando E. Rumbaut,Horiana B. Grosu,Farrah Kheradmand,Farrah Kheradmand +21 more
TL;DR: EBUS-TBNA performed under MS results in comparable diagnostic yield, rate of major complications, and patient tolerance as under GA.